News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biomarker Technologies LLC Seeking Series A Funds For Clinical Studies On New Blood Test For Breast Cancer


10/19/2005 5:13:09 PM

PHOENIX--(BUSINESS WIRE)--April 19, 2005--Biomarker Technologies LLC, the worldwide technology provider of the BT Test(TM), a blood diagnostic for the detection of breast cancer, announced today it is seeking to raise Series A Funding to conduct clinical studies of the in-vitro diagnostic test for subsequent FDA approval. The company received initial funding in 2004 from angel investors and is in due diligence with numerous potential licensees.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES